ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
about
Current perspectives on interferon Beta-1b for the treatment of multiple sclerosisUsability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population.Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS surveyAutoinjectors for administration of interferon beta-1b in multiple sclerosis: patient preferences and the ExtaviPro™ 30G and Betacomfort® devicesPatient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study.
P2860
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
ExtaviJect® 30G device for sub ...... a prospective European study.
@en
ExtaviJect® 30G device for sub ...... a prospective European study.
@nl
type
label
ExtaviJect® 30G device for sub ...... a prospective European study.
@en
ExtaviJect® 30G device for sub ...... a prospective European study.
@nl
prefLabel
ExtaviJect® 30G device for sub ...... a prospective European study.
@en
ExtaviJect® 30G device for sub ...... a prospective European study.
@nl
P2093
P2860
P356
P1476
ExtaviJect® 30G device for sub ...... a prospective European study.
@en
P2093
Francesca De Robertis
Gabriel Boeru
Mark Tomlinson
Michael Lang
Sònia Rojas-Farreras
Wojciech Kozubski
P2860
P304
P356
10.2147/MDER.S52590
P50
P577
2013-11-15T00:00:00Z